Moody's affirms Zentiva's B3 CFR; outlook stable
21/11/2019 19:37
For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_413534&WT.mc_id=AM~UmV1dGVyc05ld3NfQU1QU19OWTZfU0JfTlJfQ1ZfUmF0aW5nX05ld3NfQWxs~20191121_PR_413534
Recent news on Zentiva SA
See all newsIndia's Biocon climbs on EU nod to generic diabetes, weight-loss medication
Deals of the day-Mergers and acquisitions
Polish drug maker Polpharma working on bid for Advent's Zentiva - sources
Czech generic drug maker Zentiva denies report it is for sale (updated)
Focus: Big pharma and private equity seek healthy returns in Europe's east